{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:14Z","timestamp":1793672954565,"version":"4.5.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["13XP5113"],"award-info":[{"award-number":["13XP5113"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["C01"],"award-info":[{"award-number":["C01"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1552\/1"],"award-info":[{"award-number":["SFB 1552\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["465145163"],"award-info":[{"award-number":["465145163"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jconrel.2025.113707","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:04:44Z","timestamp":1744131884000},"page":"113707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparing continuous micromixing and extrusion downsizing for PEGylated nanoliposomes remotely loaded with doxorubicin or the steroid pro-drug methylprednisolone hemisuccinate"],"prefix":"10.1016","volume":"382","author":[{"given":"Keren","family":"Turjeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander-Nicholas","family":"Egler-Kemmerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Shamrakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Thiermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechezkel","family":"Barenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Bleul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113707_bb0005","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113707_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/biom12060784","article-title":"Nano-based approved Pharmaceuticals for Cancer Treatment: present and future challenges","volume":"12","author":"Rodr\u00edguez","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2025.113707_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115751","article-title":"Liposomes characterization for market approval as pharmaceutical products: analytical methods, guidelines and standardized protocols","volume":"236","author":"Giordani","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113707_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1078155215594415","article-title":"Is it equivalent? Evaluation of the clinical activity of single agent Lipodox\u00ae compared to single agent Doxil\u00ae in ovarian cancer treatment","volume":"22","author":"Smith","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.jconrel.2025.113707_bb0025","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/ijms24032643","article-title":"Liposomes for tumor targeted therapy: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.113707_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/pharmaceutics13071004","article-title":"Recent advances in liposomal-based anti-inflammatory therapy","volume":"13","author":"van Alem","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113707_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"Adler-Moore","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.113707_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11916-020-00905-4","article-title":"Exparel for postoperative pain management: a comprehensive review","volume":"24","author":"Kaye","year":"2020","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113707_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1039\/D2BM01252A","article-title":"Pharmaceutical liposomal delivery\u2014specific considerations of innovation and challenges","volume":"11","author":"Peng","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113707_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2025.113707_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of Patisiran (ONPATTRO\u00ae) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1359-0294(00)00090-X","article-title":"Liposome application: problems and prospects","volume":"6","author":"Barenholz","year":"2001","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"14","key":"10.1016\/j.jconrel.2025.113707_bb0075","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1021\/acsnano.2c11904","article-title":"Insights into the structure of Comirnaty Covid-19 vaccine: a theory on soft, partially bilayer-covered nanoparticles with hydrogen bond-stabilized mRNA\u2013lipid complexes","volume":"17","author":"Szebeni","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113707_bb0080","author":"Web of Science Topic Search"},{"issue":"7\u20138","key":"10.1016\/j.jconrel.2025.113707_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1049\/nbt2.12094","article-title":"The role of size in PEGylated liposomal doxorubicin biodistribution and anti-tumour activity","volume":"16","author":"Dadpour","year":"2022","journal-title":"IET Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113707_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0095","first-page":"88","article-title":"Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing","volume":"8","author":"Toh","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113707_bb0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m2","volume":"11","author":"Safra","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.113707_bb0105","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0959-8049(01)00050-8","article-title":"Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL\u00ae\/CAELYX\u00ae) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC soft tissue and bone sarcoma group","volume":"37","author":"Judson","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113707_bb0110","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1470-2045(22)00380-1","article-title":"Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial","volume":"23","author":"Pautier","year":"2022","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113707_bb0115","article-title":"Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113707_bb0120","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/ceat.201900115","article-title":"Modular manufacturing platform for continuous synthesis and analysis of versatile nanomaterials","volume":"42","author":"von Bomhard","year":"2019","journal-title":"Chem. Eng. Technol."},{"key":"10.1016\/j.jconrel.2025.113707_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/macp.201600347","article-title":"Kinetic control of block copolymer self-assembly in a micromixing device \u2013 Mechanistical insight into vesicle formation process","volume":"218","author":"Thiermann","year":"2017","journal-title":"Macromol. Chem. Phys."},{"issue":"21","key":"10.1016\/j.jconrel.2025.113707_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210704","article-title":"Complex structures made simple \u2013 continuous flow production of Core cross-linked polymeric micelles for paclitaxel pro-drug-delivery","volume":"35","author":"Bauer","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113707_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121857","article-title":"Novel microfluidic swirl mixers for scalable formulation of curcumin loaded liposomes for cancer therapy","volume":"622","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.113707_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bpc.2004.01.005","article-title":"Effects of ethanol on lipid bilayers with and without cholesterol: the distearoylphosphatidylcholine system","volume":"110","author":"Tran","year":"2004","journal-title":"Biophys. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.23230","article-title":"Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a beagle dog: a novel approach to treating autoimmune arthritis","volume":"58","author":"Avnir","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113707_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/molecules25030558","article-title":"PEGylated liposomal methyl prednisolone succinate does not induce infusion reactions in patients: a correlation between in vitro immunological and in vivo clinical studies","volume":"25","author":"Bavli","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113707_bb0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of Pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12917-018-1688-5","article-title":"Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma","volume":"14","author":"Al-Nadaf","year":"2018","journal-title":"BMC Vet. Res."},{"issue":"1 Pt A","key":"10.1016\/j.jconrel.2025.113707_bb0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbagen.2015.09.012","article-title":"Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs","volume":"1860","author":"Schilt","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphiphatic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0005-2736(95)00214-6","article-title":"Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients","volume":"1240","author":"Clerc","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113707_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/pharmaceutics8030029","article-title":"Rapid quantification and validation of lipid concentrations within liposomes","volume":"8","author":"Roces","year":"2016","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08982109209039903","article-title":"Preparation and characterization of liposomal doxorubicin for human use","volume":"2","author":"Amselem","year":"1992","journal-title":"J. Liposome Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jps.2600700217","article-title":"Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-Hemisuccinate and 17-Hemisuccinate","volume":"70","author":"Anderson","year":"1981","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113707_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-416020-0.00001-2","article-title":"Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine","volume":"104","author":"Elizondo","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/pharmaceutics13010123","article-title":"Quantitative Cryo-TEM reveals New structural details of Doxil-like PEGylated liposomal doxorubicin formulation","volume":"13","author":"Nordstr\u00f6m","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113707_bb0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2016.04.011","article-title":"Insights into composition\/structure\/function relationships of Doxil\u00ae gained from \u201chigh-sensitivity\u201d differential scanning calorimetry","volume":"104","author":"Wei","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/gps-2012-0004","article-title":"Evaluation of different micromixers by CFD simulations for the anionic polymerization of styrene","volume":"1","author":"Ziegenbalg","year":"2012","journal-title":"Green Process Synth"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113707_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130442","article-title":"Nano-drugs based on Nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases","volume":"10","author":"Turjeman","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2011.12.024","article-title":"Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines","volume":"160","author":"Ulmansky","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113707_bb0225","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/la0479105","article-title":"Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers","volume":"21","author":"Garbuzenko","year":"2005","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113707_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025721","article-title":"Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of Nano-liposomes remote loaded with glucocorticoids","volume":"6","author":"Avnir","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113707_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129849","article-title":"Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs","volume":"1865","author":"Schilt","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2025.113707_bb0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/pharmaceutics14010141","article-title":"Advanced microfluidic Technologies for Lipid Nano-Microsystems from synthesis to biological application","volume":"14","author":"Carvalho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113707_bb0255","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1039\/D3LC00821E","article-title":"Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities","volume":"24","author":"Mehraji","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2025.113707_bb0260","doi-asserted-by":"crossref","unstructured":"Lichtenberg, D.; Barenholz, Y. Liposomes: preparation, characterization, and preservation. In: Methods of biochemical analysis, Glick, D. ed., Wiley, New-York, 33, 337\u2013462, 1988. doi: https:\/\/doi.org\/10.1002\/9780470110546.ch7.","DOI":"10.1002\/9780470110546.ch7"},{"key":"10.1016\/j.jconrel.2025.113707_bb0270","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nano.2019.02.019","article-title":"Liposomes produced by microfluidics and extrusion: a comparison for scale-up purposes","volume":"18","author":"Shah","year":"2019","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113707_bb0275","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/biomedicines10061259","article-title":"Fabrication of doxorubicin-loaded lipid-based Nanocarriers by microfluidic rapid mixing","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113707_bb0280","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/ijms21051611","article-title":"Dexamethasone loaded liposomes by thin-film hydration and microfluidic procedures: formulation challenges","volume":"21","author":"Al-Amin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113707_bb0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1208\/s12248-021-00651-4","article-title":"A systematic approach for liposome and Lipodisk preclinical formulation development by microfluidic technology","volume":"23","author":"Levy","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.113707_bb0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0005-2736(85)90521-8","article-title":"Production of large unilamellar vesicles by a rapid extrusion procedure\u2014characterization of size distribution, trapped volume and ability to maintain a membrane-potential","volume":"812","author":"Hope","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.113707_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(01)00721-9","article-title":"Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics","volume":"223","author":"Berger","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113707_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0305","first-page":"26","article-title":"Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects","volume":"1","author":"Alavi","year":"2022","journal-title":"Micro Nano Bio Asp."},{"key":"10.1016\/j.jconrel.2025.113707_bb0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2005.02.001","article-title":"Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization-extrusion technique","volume":"104","author":"Pupo","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113707_bb0315","series-title":"Emerging Technologies for Nanoparticle Manufacturing","first-page":"263","article-title":"High-pressure homogenization techniques for nanoparticles","author":"Vinchhi","year":"2021"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1466-8564(00)00012-6","article-title":"Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions","volume":"1","author":"Floury","year":"2000","journal-title":"Innov. Food Sci. Emerg. Technol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113707_bb0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639048909040205","article-title":"The size reduction of liposomes with a high pressure homogenizer (microfluidizer\u2122). Characterization of prepared dispersions and comparison with conventional methods","volume":"15","author":"Talsma","year":"1989","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"13","key":"10.1016\/j.jconrel.2025.113707_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002196","article-title":"Recent developments in nanomaterial-based shear-sensitive drug delivery systems","volume":"10","author":"Wang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113707_bb0335","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ceat.200407163","article-title":"Mixers with microstructured foils for chemical production purposes","volume":"28","author":"Werner","year":"2005","journal-title":"Chem. Eng. Technol."},{"key":"10.1016\/j.jconrel.2025.113707_bb0340","author":"European Medicines Agency"},{"key":"10.1016\/j.jconrel.2025.113707_bb0345","author":"Tribioscience Product Portfolio"},{"issue":"28","key":"10.1016\/j.jconrel.2025.113707_bb0350","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1021\/acs.langmuir.1c01005","article-title":"Parametric study of the factors influencing liposome physicochemical characteristics in a periodic disturbance mixer","volume":"37","author":"L\u00f3pez","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.113707_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2024.106769","article-title":"Antisolvent fabrication of monodisperse liposomes using novel ultrasonic microreactors: process optimization, performance comparison and intensification effect","volume":"103","author":"Peng","year":"2024","journal-title":"Ultrason. Sonochem."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.113707_bb0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2015.02.063","article-title":"Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug","volume":"485","author":"Kastner","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113707_bb0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2016.09.027","article-title":"Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs","volume":"514","author":"Joshi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113707_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120711","article-title":"Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics","volume":"604","author":"Gkionis","year":"2021","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:58:14Z","timestamp":1777870694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592500327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":71,"alternative-id":["S016836592500327X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113707","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing continuous micromixing and extrusion downsizing for PEGylated nanoliposomes remotely loaded with doxorubicin or the steroid pro-drug methylprednisolone hemisuccinate","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113707"}}